Fluticasone propionate 100 mcg

DRUG3 trials

Sponsors

Novartis Pharmaceuticals, GlaxoSmithKline, University of Medicine and Pharmacy at Ho Chi Minh City

Conditions

Allergic Rhinitis (AR)AsthmaPersistent Asthma

Phase 3

A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects

CompletedNCT02094937

GlaxoSmithKlineAsthma

Start: 2014-03-27End: 2015-08-28Updated: 2017-05-25

Phase 4

Study of Safety of Foradil in Patients With Persistent Asthma

TerminatedNCT01845025

Novartis PharmaceuticalsPersistent Asthma

Start: 2013-05-31End: 2016-05-31Updated: 2017-03-21

Unknown Phase

Evaluation of the Adjunctive Effects of Moxibustion in the Treatment of Cold-Syndrome Allergic Rhinitis

Not yet recruitingNCT07537439

University of Medicine and Pharmacy at Ho Chi Minh CityAllergic Rhinitis (AR)

Start: 2026-04-13End: 2026-10-01Target: 60Updated: 2026-04-17